|
KALRN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.784600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.471000E-01 |
| Normal-vs-Stage2 |
3.745600E-01 |
| Normal-vs-Stage3 |
1.938180E-01 |
| Normal-vs-Stage4 |
1.873380E-01 |
| Stage1-vs-Stage2 |
1.802810E-01 |
| Stage1-vs-Stage3 |
6.344300E-02 |
| Stage1-vs-Stage4 |
9.238200E-02 |
| Stage2-vs-Stage3 |
5.791500E-02 |
| Stage2-vs-Stage4 |
5.603800E-02 |
| Stage3-vs-Stage4 |
8.935800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.046200E-01 |
| Normal-vs-AfricanAmerican |
1.421420E-01 |
| Normal-vs-Asian |
9.056500E-02 |
| Caucasian-vs-AfricanAmerican |
2.174400E-02 |
| Caucasian-vs-Asian |
5.583300E-03 |
| AfricanAmerican-vs-Asian |
6.906400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.947200E-01 |
| Normal-vs-Female |
4.486200E-01 |
| Male-vs-Female |
2.864400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.744800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.398400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.360400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.221600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.631800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.102600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.700000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.189800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.210200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.156100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.209700E-04 |
| Classical-VS-Follicular |
5.223400E-01 |
| Classical-VS-Other |
6.216600E-01 |
| Classical-VS-Normal |
6.666000E-01 |
| Tall-VS-Follicular |
6.097200E-03 |
| Tall-VS-Other |
2.426000E-01 |
| Tall-VS-Normal |
5.954400E-02 |
| Follicular-VS-Other |
8.013200E-01 |
| Follicular-VS-Normal |
9.918000E-01 |
| Other-VS-Normal |
8.366400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.683200E-01 |
| Normal-vs-N1 |
3.068800E-01 |
| N0-vs-N1 |
2.161000E-01 |
|
|
